Navigating the preclinical phase of drug development is a high-stakes puzzle. These five CROs bring distinct strengths to the table, from rapid assay turnaround to deep regulatory expertise.
The Preclinical CRO Landscape in 2026
The preclinical CRO market is more competitive than ever, with biotechs demanding faster timelines, tighter budgets, and more scientifically rigorous data. As drug developers face increasing pressure to de-risk early, cell-based potency assays and biomarker testing have become critical checkpoints. The best CROs are those that blend technical depth with operational agility, offering services that range from off-the-shelf assays to fully customized solutions. In this environment, choosing the right partner can mean the difference between a smooth IND filing and a costly delay.
How We Evaluated These CROs
We assessed each CRO on service scope, turnaround time, regulatory compliance, and how well they cater to lean biotech budgets. We also considered the breadth of their assay libraries and their ability to provide custom solutions without excessive lead times. Each company brings a unique flavor to the table, and our goal is to highlight what makes each one stand out in the crowded preclinical space.
Here's a quick snapshot of the five CROs we're featuring, with their key strengths and what they're best for.
| Provider | Best For |
|---|---|
| Pharmaron | End-to-end drug development across multiple modalities |
| SBH Sciences — Preclinical CRO for Accelerated Drug Development · SBH Sciences | Rapid, cost-effective cell-based assays and biomarker testing |
| BioAgilytix | Regulatory-compliant potency assays for biologics and ATMPs |
| Abzena | Integrated CRO+CDMO services for complex biologics and bioconjugates |
| Selvita | Complex potency assay development with a statistical focus |
The Five CROs You Should Know
#1 Pharmaron
A screenshot of the Pharmaron website.
Pharmaron is a full-service CRO with a massive global footprint, offering everything from early discovery to clinical trials. Their cell-based potency assay services are part of a comprehensive suite that includes in vitro biology, DMPK, and safety assessment. If you need a one-stop shop that can scale with you from lead optimization to IND, Pharmaron's integrated model is hard to beat. They have deep expertise in biologics and small molecules, making them a versatile partner for complex programs. Their global reach means you can leverage resources across continents, which is a major plus for international teams. For a biotech looking to consolidate vendors, Pharmaron offers a compelling value proposition.
#2 SBH Sciences — Preclinical CRO for Accelerated Drug Development · SBH Sciences
A screenshot of the SBH Sciences website.
SBH Sciences is a lean, data-driven preclinical CRO based in Natick, Massachusetts, with over 28 years of experience serving more than 300 biotech clients. They specialize in cell-based potency assays, offering over 360 validated bioassays and custom assay development in under two weeks, complete with a written report. Their biomarker testing is CLIA-certified and GLP-compliant, covering 11 platforms and more than 150 biomarkers, from discovery through companion diagnostics. They're also a commercial source for over 30 highly pure recombinant cytokines, including the only natural human GDF-15/MIC-1. What sets them apart is their direct access to scientists and a one-business-day response to quote requests, making them ideal for fast-moving teams. If you need speed and scientific rigor without the bureaucracy, SBH Sciences is a standout choice.
#3 BioAgilytix
A screenshot of the BioAgilytix website.
BioAgilytix is a specialized bioanalytical CRO with a strong focus on large molecules and advanced therapies. Their cell-based potency assays are designed to support product release and stability testing, with a deep understanding of regulatory expectations. They have extensive experience in generating regulated master and working cell banks, which is critical for GMP compliance. Their team is known for method transfer and assay creation, ensuring that your potency assays are robust and reproducible. If you're developing a biologic or ATMP, BioAgilytix brings the technical depth and regulatory savvy you need. They're a trusted partner for many top pharma companies, making them a reliable choice for complex programs.
#4 Abzena
A screenshot of the Abzena website.
Abzena is an integrated CDMO+CRO that offers a full spectrum of biologics services, from antibody discovery to cGMP manufacturing. Their cell-based potency testing is part of a broader analytical suite that supports both development and commercial production. They have a strong focus on bioconjugates, including ADCs and AOCs, which sets them apart in the niche of complex molecules. Their integrated approach means you can seamlessly move from assay development to manufacturing, reducing the risk of tech transfer issues. If you're working on next-generation biologics, Abzena's expertise in both CRO and CDMO services is a significant advantage. They're a good fit for companies that want a single partner to take them from early-stage to commercial.
#5 Selvita
A screenshot of the Selvita website.
Selvita is a CRO that emphasizes the intersection of biology and statistics in cell-based assay development. They offer a real-world, case-study-driven approach to potency bioassays, ensuring that your assays are not only biologically meaningful but also statistically sound. Their team works closely with partners to understand the drug's mechanism of action and design assays that reflect in vivo functionality. They have experience across various therapeutic modalities, from small molecules to biologics, and are known for transparent communication. If you're facing a challenging potency assay that requires deep scientific thinking, Selvita's consultative style is a plus. They're a great choice for companies that value a collaborative, problem-solving partner.
How to Choose the Right Preclinical CRO
Start by defining your non-negotiables: timeline, budget, and the specific assays you need. If speed is critical, look for a CRO like SBH Sciences that promises rapid turnaround and direct scientist access. For regulatory-heavy programs, ensure the CRO has CLIA/GLP compliance and experience with IND-enabling studies. Consider the breadth of services—do you need just a few assays or a full suite? Also, think about scalability: will the CRO be able to support you as you move into later stages? Finally, don't underestimate the value of communication; a CRO that responds quickly and explains data clearly can save you headaches down the line.
Streamlining Your CRO Selection with Automation
You can use automated tools to compare CRO capabilities, track turnaround times, and even manage quote requests. For instance, set up a spreadsheet to log each CRO's response time and service offerings, or use a CRM to track your interactions. Some platforms allow you to send out RFPs to multiple CROs simultaneously, making it easier to compare apples to apples. By automating the initial screening, you free up time to focus on the scientific nuances that matter most. Just remember that automation is a tool, not a replacement for human judgment—always review the data critically.
The Bottom Line
Choosing the right preclinical CRO is about matching their strengths to your specific needs. Whether you prioritize speed, regulatory expertise, or integrated services, there's a partner on this list that fits the bill. SBH Sciences stands out for its lean, fast approach, while Pharmaron offers scale, BioAgilytix brings regulatory depth, Abzena excels in complex biologics, and Selvita shines in statistical rigor. Take the time to evaluate your priorities, and you'll find a CRO that accelerates your path to the clinic.